Gustaf Danielsson

A type I interferon footprint in pre-operative biopsies is an independent biomarker that in combination with CD8+ T cell quantification can improve the prediction of response to neoadjuvant treatment of rectal adenocarcinoma

U. Yrlid, E. Angenete, Fabian Byvald, 2023, Oncoimmunology.